Pharmacological force of Xeloda

Xeloda (capecitabine) is a cytostatic. Capecitabine is a obtained of fluoropyrimidine carbamate, which was developed as an pronounced cytostatic, activated in tumor accumulation and rendered it not a discriminating cytotoxic effect. In vitro xeloda does not contain a cytotoxic effect. However, in vivo it is converted into a cytotoxic aggravate - fluorouracil (5-FU), which undergoes further metabolism. The development of 5-FU occurs in the tumor accumulation under the mastery of tumor angiogenic factors - thymidine (dTdFazy), which thus minimizes systemic orientation to 5-FU on nourishing tissues. As a emerge of selective activation of the volume of 5-FU in the tumor significantly it is higher than the levels in fine fettle tissues.

To swatting the picky combat of xeloda in tumor was conducted pharmacokinetic experiment comparing capecitabine concentration in the tumor, healthy tissue and plasma of cancer patients. Following verbal supervision of xeloda cost (1255 mg/m2 amount twice a age as a remedy for 5-7 days ahead of surgery), a concentration of 5-FU in primary tumor were significantly higher than in circumjacent bracing pack (geometric mean ratio 2.5) and plasma (the proportion geometric backing 14). The endeavour of thymidine phosphorylase in the primary tumor is 4 times higher than in healthy tissue. In human tumors, such as breast, paunch, and rectum, cervical and ovarian cancer, with a end more thymidine is adept to convert 5'-DFUR (5'-deoxy-5-fluorouridine) to 5-FU than in strong tissues.

Multifarious people allow capecitabine because they skilled in that both healthy and tumor cells metabolize 5-FU to 5-fluoro-2-deoxyuridine monophosphate (FdUMF) and 5-fluorouridine triphosphate (FUTF). These metabolites justification invoice to cells from one end to the other two particular mechanisms. Beforehand, folate and FdUMF cofactor N5-10-methylenetetrahydrofolate bind to thymidylate synthase in the development of covalently destined tertiary sector. This binding inhibits the disposition of thymidylate from uracil. Thymidylate is a inexorable vanguard of thymidine triphosphate, which in make up is essential for DNA compound, so the fall short of of this stuff can supervise to impediment of cell dividing. Secondly, in the merging of RNA transcription enzyme core may incorrectly count a FUTF as an alternative of uridine triphosphate (UTP). This metabolic "wickedness" violates the processing of RNA and protein synthesis.

Antitumor energy of capecitabine generic was evaluated in patients with heart of hearts cancer station IV. This grouping of patients who already received a enormous analysis, has been refractory to previous treatment with paclitaxel conducted. In as well, 41% of patients were resistant and 26% withdraw the for all practical purposes of earlier therapy with anthracyclines, 82% of patients had already received 5-FU. That is why diverse patients with cancer bribe capecitabine. The inform endpoint of the consider was objective tumor shrinkage (where they can be resolved). Remission was considered a reduction in the diameter of the tumor not less than 50% allowing for regarding at least 1 month. xeloda 500mg price was administered at a continuously quantity of 2510 mg/m2 for 2 weeks, then did a week ruin and re-administered the drug in the profile of a three-week cycles.